Literature DB >> 10854108

Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?

M Hiltunen1, S Helisalmi, A Mannermaa, I Alafuzoff, A M Koivisto, M Lehtovirta, M Pirskanen, R Sulkava, A Verkkoniemi, H Soininen.   

Abstract

Mutations in the presenilin-1 (PS-1) gene have been shown to cause early onset Alzheimer's disease (EOAD) in an autosomal dominant manner. We have identified a novel 4.6-kb genomic deletion in the PS-1 gene in a Finnish EOAD family, which leads to an inframe exclusion of exon9 (delta9) from the mRNA transcript. This germline mutation results in a similar alteration in mRNA level as previously described with the variant AD and the delta9 splice-site mutations. In this present EOAD family, the clinical and neuropathological phenotype of patients are those of the typical AD without indications of spastic paraparesis or 'cotton wool' plaques, which are the hallmarks of the variant AD. A sequence analysis of the deletion crossover site of the mutant and corresponding wild type regions revealed complete homology with the recombigenic 26 bp Alu core sequence at intron 8. In addition, a segment at the intron 9 breakpoint displayed homology with the core sequence, but comparison of the 5' and 3' breakpoint sequences did not reveal significant identity favouring involvement of Alu core sequence-stimulated non-homologous recombination rather than Alu-mediated homologous pairing of the fragments. This study shows that large genomic rearrangements can affect the EOAD gene PS-1 through a mechanism, which may involve Alu core sequence-stimulated recombination.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854108     DOI: 10.1038/sj.ejhg.5200423

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

1.  Detection of recombinant products during PCR amplification of DNA containing direct alu repeats.

Authors:  D V Shibalev; A S Voronov; V N Bashkirov; N S Kupriyanova; A P Ryskov
Journal:  Dokl Biochem Biophys       Date:  2003 Jan-Feb       Impact factor: 0.788

2.  Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1.

Authors:  Orly Lazarov; Gerardo A Morfini; Gustavo Pigino; Archana Gadadhar; Xiangjun Chen; John Robinson; Hanson Ho; Scott T Brady; Sangram S Sisodia
Journal:  J Neurosci       Date:  2007-06-27       Impact factor: 6.167

3.  The presenilin loop region is essential for glycogen synthase kinase 3 β (GSK3β) mediated functions on motor proteins during axonal transport.

Authors:  Rupkatha Banerjee; Zoe Rudloff; Crystal Naylor; Michael C Yu; Shermali Gunawardena
Journal:  Hum Mol Genet       Date:  2018-09-01       Impact factor: 6.150

4.  Presenilin-1 Delta E9 Mutant Induces STIM1-Driven Store-Operated Calcium Channel Hyperactivation in Hippocampal Neurons.

Authors:  Maria Ryazantseva; Anna Goncharova; Kseniia Skobeleva; Maksim Erokhin; Axel Methner; Pavel Georgiev; Elena Kaznacheyeva
Journal:  Mol Neurobiol       Date:  2017-07-13       Impact factor: 5.590

Review 5.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 6.  The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.

Authors:  Ekaterina Rogaeva
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

7.  17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.

Authors:  K Le Guennec; O Quenez; G Nicolas; D Wallon; S Rousseau; A-C Richard; J Alexander; P Paschou; C Charbonnier; C Bellenguez; B Grenier-Boley; D Lechner; M-T Bihoreau; R Olaso; A Boland; V Meyer; J-F Deleuze; P Amouyel; H M Munter; G Bourque; M Lathrop; T Frebourg; R Redon; L Letenneur; J-F Dartigues; O Martinaud; O Kalev; S Mehrabian; L Traykov; T Ströbel; I Le Ber; P Caroppo; S Epelbaum; T Jonveaux; F Pasquier; A Rollin-Sillaire; E Génin; L Guyant-Maréchal; G G Kovacs; J-C Lambert; D Hannequin; D Campion; A Rovelet-Lecrux
Journal:  Mol Psychiatry       Date:  2016-12-13       Impact factor: 15.992

8.  The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.

Authors:  Amy Gerrish; Giancarlo Russo; Alexander Richards; Valentina Moskvina; Dobril Ivanov; Denise Harold; Rebecca Sims; Richard Abraham; Paul Hollingworth; Jade Chapman; Marian Hamshere; Jaspreet Singh Pahwa; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Janet A Johnston; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Heike Kölsch; Reinhard Heun; Britta Schürmann; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Gail Davies; Sarah E Harris; John M Starr; Ian J Deary; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Lesley Jones; Peter A Holmans; Michael C O'Donovan; Michael J Owen; Julie Williams
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

9.  Genetics of dementia in a Finnish cohort.

Authors:  Petra Pasanen; Liisa Myllykangas; Minna Pöyhönen; Anna Kiviharju; Maija Siitonen; John Hardy; Jose Bras; Anders Paetau; Pentti J Tienari; Rita Guerreiro; Auli Verkkoniemi-Ahola
Journal:  Eur J Hum Genet       Date:  2018-02-23       Impact factor: 4.246

Review 10.  Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.

Authors:  Tamar Smit; Natasja A C Deshayes; David R Borchelt; Willem Kamphuis; Jinte Middeldorp; Elly M Hol
Journal:  Glia       Date:  2021-02-25       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.